PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Utah Medical Products, Inc. (UTMD)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS9174881089
CUSIP917488108
SectorHealthcare
IndustryMedical Instruments & Supplies

Highlights

Market Cap$230.57M
EPS (TTM)$4.33
PE Ratio15.30
Total Revenue (TTM)$34.07M
Gross Profit (TTM)$18.74M
EBITDA (TTM)$14.55M
Year Range$64.90 - $86.41
Short %2.15%
Short Ratio3.20

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: UTMD vs. DHR, UTMD vs. FDFIX, UTMD vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Utah Medical Products, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%MayJuneJulyAugustSeptemberOctober
-1.12%
16.33%
UTMD (Utah Medical Products, Inc.)
Benchmark (^GSPC)

Returns By Period

Utah Medical Products, Inc. had a return of -20.27% year-to-date (YTD) and -20.07% in the last 12 months. Over the past 10 years, Utah Medical Products, Inc. had an annualized return of 4.37%, while the S&P 500 had an annualized return of 11.99%, indicating that Utah Medical Products, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-20.27%22.49%
1 month-1.20%3.72%
6 months-1.12%16.33%
1 year-20.07%33.60%
5 years (annualized)-5.58%14.41%
10 years (annualized)4.37%11.99%

Monthly Returns

The table below presents the monthly returns of UTMD, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-5.95%-11.40%1.76%-6.90%3.16%-1.73%4.18%-2.31%-1.15%-20.27%
2023-8.36%-0.38%3.59%0.07%-1.42%0.00%5.50%-6.84%-5.79%-7.53%6.01%0.26%-15.10%
2022-5.93%-4.32%0.16%-5.86%1.83%0.07%6.33%0.61%-6.86%4.97%-0.55%13.23%1.87%
20212.81%-2.62%2.92%0.76%-1.78%-0.45%5.13%-0.89%5.11%4.30%15.21%-8.72%21.95%
2020-14.67%-5.07%7.94%-11.75%19.86%-10.66%-8.03%0.80%-2.43%3.92%4.01%-2.05%-20.88%
201913.07%-9.64%4.30%-4.36%-5.51%20.40%-4.92%8.06%-2.25%6.92%4.25%1.28%31.43%
201810.69%-1.55%11.76%2.73%3.05%5.52%-11.94%-6.34%3.98%-7.45%8.84%-12.18%3.22%
2017-14.50%-0.48%1.08%0.48%7.35%8.14%-4.56%4.41%2.30%2.52%8.29%0.02%13.56%
2016-3.71%5.11%6.00%6.97%-2.18%-3.35%3.29%-3.17%-4.70%3.93%9.73%7.07%26.28%
2015-5.60%4.78%1.20%-9.94%1.52%9.44%-8.32%-2.34%1.38%9.47%-4.21%4.10%-0.74%
2014-6.93%3.36%5.63%-12.17%7.91%-5.71%1.11%0.15%-5.94%16.49%2.24%3.87%7.00%
201311.51%3.11%18.24%-9.10%4.38%17.96%2.80%-9.53%18.27%-6.36%-4.40%7.97%61.75%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of UTMD is 10, indicating that it is in the bottom 10% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of UTMD is 1010
Combined Rank
The Sharpe Ratio Rank of UTMD is 55Sharpe Ratio Rank
The Sortino Ratio Rank of UTMD is 66Sortino Ratio Rank
The Omega Ratio Rank of UTMD is 99Omega Ratio Rank
The Calmar Ratio Rank of UTMD is 1717Calmar Ratio Rank
The Martin Ratio Rank of UTMD is 1414Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Utah Medical Products, Inc. (UTMD) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


UTMD
Sharpe ratio
The chart of Sharpe ratio for UTMD, currently valued at -0.85, compared to the broader market-4.00-2.000.002.004.00-0.85
Sortino ratio
The chart of Sortino ratio for UTMD, currently valued at -1.20, compared to the broader market-4.00-2.000.002.004.00-1.20
Omega ratio
The chart of Omega ratio for UTMD, currently valued at 0.87, compared to the broader market0.501.001.502.000.87
Calmar ratio
The chart of Calmar ratio for UTMD, currently valued at -0.45, compared to the broader market0.002.004.006.00-0.45
Martin ratio
The chart of Martin ratio for UTMD, currently valued at -1.17, compared to the broader market-10.000.0010.0020.0030.00-1.17
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.69, compared to the broader market-4.00-2.000.002.004.002.69
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.58, compared to the broader market-4.00-2.000.002.004.003.59
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.49, compared to the broader market0.501.001.502.001.49
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.37, compared to the broader market0.002.004.006.002.37
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 16.43, compared to the broader market-10.000.0010.0020.0030.0016.43

Sharpe Ratio

The current Utah Medical Products, Inc. Sharpe ratio is -0.85. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Utah Medical Products, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00MayJuneJulyAugustSeptemberOctober
-0.85
2.69
UTMD (Utah Medical Products, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

Utah Medical Products, Inc. granted a 1.81% dividend yield in the last twelve months. The annual payout for that period amounted to $1.20 per share.


PeriodTTM20232022202120202019201820172016201520142013
Dividend$1.20$1.19$1.17$2.84$1.10$1.09$1.07$1.05$1.03$1.01$0.99$0.97

Dividend yield

1.81%1.41%1.16%2.84%1.31%1.01%1.28%1.28%1.41%1.72%1.64%1.69%

Monthly Dividends

The table displays the monthly dividend distributions for Utah Medical Products, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.30$0.00$0.90
2023$0.00$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.30$0.00$0.00$0.30$1.19
2022$0.00$0.00$0.29$0.00$0.00$0.29$0.00$0.00$0.29$0.00$0.00$0.30$1.17
2021$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.00$2.00$2.84
2020$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$0.00$0.00$0.28$1.10
2019$0.00$0.00$0.27$0.00$0.00$0.27$0.00$0.00$0.27$0.00$0.00$0.28$1.09
2018$0.00$0.00$0.27$0.00$0.00$0.27$0.00$0.00$0.27$0.00$0.00$0.27$1.07
2017$0.00$0.00$0.26$0.00$0.00$0.26$0.00$0.00$0.26$0.00$0.00$0.27$1.05
2016$0.00$0.00$0.26$0.00$0.00$0.26$0.00$0.00$0.26$0.00$0.00$0.26$1.03
2015$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.26$1.01
2014$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.99
2013$0.24$0.00$0.00$0.24$0.00$0.00$0.24$0.00$0.00$0.25$0.97

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%1.8%
Utah Medical Products, Inc. has a dividend yield of 1.81%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%27.7%
Utah Medical Products, Inc. has a payout ratio of 27.71%, which is quite average when compared to the overall market. This suggests that Utah Medical Products, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-40.00%-30.00%-20.00%-10.00%0.00%MayJuneJulyAugustSeptemberOctober
-43.70%
-0.30%
UTMD (Utah Medical Products, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Utah Medical Products, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Utah Medical Products, Inc. was 76.72%, occurring on Sep 10, 1998. Recovery took 1207 trading sessions.

The current Utah Medical Products, Inc. drawdown is 43.70%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-76.72%Mar 1, 1996639Sep 10, 19981207Jul 23, 20031846
-71.41%Aug 29, 1985545Oct 29, 1987355Mar 29, 1989900
-60.72%Jan 10, 1992632Jul 11, 1994295Sep 8, 1995927
-44.75%Nov 23, 2021722Oct 8, 2024
-38.18%Jul 6, 199035Aug 23, 1990107Jan 25, 1991142

Volatility

Volatility Chart

The current Utah Medical Products, Inc. volatility is 3.34%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%MayJuneJulyAugustSeptemberOctober
3.34%
3.03%
UTMD (Utah Medical Products, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Utah Medical Products, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Utah Medical Products, Inc. compared to its peers in the Medical Instruments & Supplies industry.


PE Ratio
100.0200.0300.0400.015.3
The chart displays the price to earnings (P/E) ratio for UTMD in comparison to other companies of the Medical Instruments & Supplies industry. Currently, UTMD has a PE value of 15.3. This PE value is considered to be low compared to the rest of the industry.
PEG Ratio
0.05.010.015.020.00.0
The chart displays the price to earnings to growth (PEG) ratio for UTMD in comparison to other companies of the Medical Instruments & Supplies industry. Currently, UTMD has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Utah Medical Products, Inc..


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items